Please provide your email address to receive an email when new articles are posted on . Approximately 40,000 people in the United States have skin sarcoidosis and there is no FDA-approved treatment.

Sirolimus may be an effective treatment for patients with persistent cutaneous sarcoidosis. In a small clinical trial, 7 of 10 patients treated with sirolimus via oral solution had improvements in ...

Not many people know how to say sarcoidosis (sar-coy-doe-sis). If people can’t say it, it is challenging to raise awareness, educate others about the disease, discuss the disease with physicians and ...

Sarcoidosis is a rare systemic disease that afflicts an estimated 200,000 people in the US, more often people who are Black and more women than men, particularly when it causes chronic skin disease.

Please provide your email address to receive an email when new articles are posted on . Patients treated with the JAK inhibitor tofacitinib saw a dose-dependent response in the treatment of cutaneous ...

A research team led by Georg Stary (Medical University of Vienna and CeMM) has identified a new approach to treating the inflammatory disease sarcoidosis. In a clinical study, the inhibition of a ...